Skip to main content
. 2018 Jul 18;38(6):530–537. doi: 10.3343/alm.2018.38.6.530

Table 2. Cross-reactivity of insulin analogues in the Lumipulse G1200 and Roche E170 systems.

Concentration (pmol/L) Detection level (cross-reactivity %)
Humulin Insulin lispro Insulin detemir Insulin aspart Insulin glulisine Insulin glargine
G1200 E170 G1200 E170 G1200 E170 G1200 E170 G1200 E170 G1200 E170
6,940 > 100% > 100% < 0.1% < 0.2% < 0.1% < 0.2% 0.16% < 0.2% 0.28% 0.32% 9.3% < 0.2%
694 > 100% > 100% < 0.1% < 0.2% < 0.1% < 0.2% < 0.1% < 0.2% 1.4% 2.6% 6.3% < 0.2%
69.4 > 100% > 100% < 0.1% < 0.2% < 0.1% < 0.2% < 0.1% < 0.2% 0.3% 1.1% 2.0% < 0.2%
6.94 > 100% > 100% < 0.1% < 0.2% < 0.1% < 0.2% < 0.1% < 0.2% < 0.1% < 0.2% < 0.1% < 0.2%